Novel Therapeutic Treatments to Targeting Tinnitus

Time: 4:45 pm
day: Day Two

Details:

• Background on tinnitus population, disease burden and pathophysiology
• Potential treatment using sustained-exposure formulation of gacyclidine (OTO-313)
• Review of OTO-313 Phase 1/2 clinical results

Speakers: